Osaka, Japan

Yuko Kawano

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Tanabe Pharma Corporation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yuko Kawano. Retrieved from https://idiyas.com/inventor/yuko-kawano

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yuko Kawano: Innovator in Melanocortin Research

Introduction

Yuko Kawano is a prominent inventor based in Osaka, Japan. She has made significant contributions to the field of pharmacology, particularly through her innovative research on melanocortin receptors. Her work has the potential to impact various therapeutic areas.

Latest Patents

Yuko Kawano holds a patent for a "Novel Use of Melanocortin-1 Receptor Agonist." This patent highlights her pioneering approach to utilizing melanocortin-1 receptor agonists in novel applications, showcasing her expertise and creativity in the field.

Career Highlights

Kawano is currently employed at Tanabe Pharma Corporation, where she continues to advance her research and development efforts. Her role at the company allows her to collaborate with other talented professionals in the industry.

Collaborations

Some of her notable coworkers include Masahiro Kondo and Tsuyoshi Suzuki. Together, they contribute to the innovative environment at Tanabe Pharma Corporation, fostering advancements in pharmaceutical research.

Conclusion

Yuko Kawano is a remarkable inventor whose work on melanocortin receptors exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions are paving the way for future advancements in therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…